化疗初治乳腺癌癌因性疲乏的脑FDG PET/CT代谢相关研究
本研究回顾性纳入20例未接受化疗的乳腺癌癌因性疲乏患者,在疲乏诊断前后行全身[18F]FDG-PET/CT脑部影像分析。结果显示诊断后双侧及左侧丘脑相对葡萄糖代谢显著升高,右侧前扣带回代谢显著降低。研究提示丘脑、基底节及边缘系统代谢改变可能是独立于化疗的癌因性疲乏中枢神经相关因素。
要点
- 癌因性疲乏患者FDG PET显示丘脑相对高代谢及右侧前扣带回低代谢,可作为阅片时关注区域。
- 未化疗乳腺癌患者出现上述脑代谢改变时,需考虑癌因性疲乏的中枢机制而非治疗毒性。
- 基底节及边缘系统代谢增高趋势提示关注深部灰质核团在疲乏评估中的价值。
核心结论
- 化疗初治乳腺癌癌因性疲乏患者存在丘脑、基底节及边缘系统相对葡萄糖代谢改变,提示中枢神经机制可能独立于化疗影响。
- 这是首项使用高灵敏度[18F]FDG PET/CT探讨化疗初治乳腺癌癌因性疲乏脑代谢相关性的研究。
研究设计与样本
- 回顾性纵向研究,纳入20例连续成人乳腺癌伴癌因性疲乏(ICD-10-CM R53.0)且从未接受化疗的患者,时间为2023年1月至2025年8月。
- 采用Biograph Vision Quadra扫描仪行全身[18F]FDG-PET/CT,基线扫描为疲乏诊断前1年内,随访扫描为疲乏诊断后3个月内。
- 排除脑转移或其他已知疲乏原因的患者,分析采用基于Atlas的双侧及左右半球独立感兴趣区分析比较两次扫描。
关键影像表现/征象
- 疲乏诊断后双侧丘脑相对葡萄糖代谢显著升高,左侧丘脑亦显著升高。
- 疲乏诊断后右侧前扣带回相对代谢显著降低。
- 双侧及右侧压后皮质呈现代谢降低趋势,右侧苍白球与右侧杏仁核呈现代谢升高趋势。
诊断标准与关键数值
- 双侧丘脑相对代谢升高:T = -2.23,P = 0.05。
- 左侧丘脑相对代谢升高:T = -2.59,P = 0.03。
- 右侧前扣带回相对代谢降低:T = 2.28,P = 0.05。
- 压后皮质代谢降低趋势:双侧 T = 1.40,P = 0.19;右侧 T = 1.78,P = 0.11。
- 右侧苍白球代谢升高趋势:T = -1.53,P = 0.16;右侧杏仁核代谢升高趋势:T = -1.62,P = 0.14。
临床应用与阅片要点
- 报告乳腺癌患者脑FDG PET/CT时,应关注丘脑、前扣带回、基底节及边缘系统的相对代谢异常。
- 丘脑高代谢与右侧前扣带回低代谢可作为癌因性疲乏的潜在影像参考,在排除脑转移后帮助解释患者症状。
- 对化疗前即出现疲乏的乳腺癌患者,阅片时不应将脑代谢异常简单归因于治疗相关改变。
局限性
- 本研究样本量为20例连续患者,样本较小。
- 回顾性研究设计存在固有偏倚风险。
- 趋势性结果未达统计学显著,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Cancer-related fatigue (CRF) is a prevalent and debilitating symptom in cancer patients, and its underlying pathophysiology remains poorly understood, particularly in patients who have not undergone chemotherapy. This study aimed to investigate the cerebral metabolic changes associated with CRF in chemotherapy-naïve breast cancer patients using high-resolution [18F]fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG-PET/CT).
METHODS: We retrospectively identified 20 consecutive adult patients with breast cancer who were diagnosed with CRF (ICD-10-CM R53.0) and had never received chemotherapy between January 2023 and August 2025. Patients underwent whole-body [18F]FDG-PET/CT imaging on a Biograph Vision Quadra scanner at baseline (up to 1 year before CRF diagnosis while having breast cancer) and at the time of CRF diagnosis, up to three months after the date of diagnosis. Brain image slices were extracted and preprocessed. Patients with brain metastases or other known causes of fatigue were excluded. The analysis used an Atlas-based region-of-interest analysis of bilateral regions, as well as separate right and left hemispheres, to compare the two scans and identify significant metabolic changes.
RESULTS: A significant increase in relative glucose metabolism was observed in the bilateral thalamus (T = -2.23, P = 0.05) and left thalamus (T = -2.59, P = 0.03). A significant decrease in relative metabolism was observed in the right anterior cingulate gyrus (T = 2.28, P = 0.05) following CRF diagnosis. A trend towards decreased metabolism in the retrosplenial cortex was also noted (1.40, P = 0.19; and 1.78, P = 0.11 for bilateral and right hemisphere, respectively). Additionally, the right Globus Pallidus (-1.53, P = 0.16) and right Amygdala (-1.62, P = 0.14) showed a trend toward increased metabolism following the diagnosis of CRF.
CONCLUSION: This is the first study to investigate brain metabolic correlates of CRF in a chemotherapy-naïve breast cancer population using a high-sensitivity Brain [18F]FDG PET/CT. The observed hypermetabolism in the thalamus and other regions of the basal ganglia and limbic system suggests potential central neurobiological correlates of CRF, independent of chemotherapy effects. These findings provide a foundation for future research into imaging biomarkers for CRF and their application to the development of targeted therapeutic interventions.
引用
- Msherghi, Wong, Xu, et al. Neurobiological Correlates of Cancer-Related Fatigue in Chemotherapy-Naïve Breast Cancer: A Retrospective Longitudinal [18F]FDG PET/CT Study. AJNR Am J Neuroradiol. 2026. PMID: 42629166. doi:10.3174/ajnr.A9602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。